Regular ArticleMetastatic bone disease: clinical features, pathophysiology and treatment strategies
References (54)
- et al.
Use of bisphosphonates for the treatment of bone metastasis in experimental animal models
Cancer Treat Rev
(1999) - et al.
Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival
Eur J Cancer
(1990) - et al.
How is androgen dependent metastatic prostate cancer best treated?
Haematol Oncol Clinics North Am
(1996) - et al.
C-reactive protein and 2 microglobulin produce a simple and powerful myeloma staging system
Blood
(1992) - et al.
A prospective, randomised double-blind crossover study to examine the efficacy of strontium89in pain palliation in patients with advanced prostate cancer metastatic to bone
Eur J Cancer
(1991) - et al.
A dose-controlled study of153Sm-Ethylenediaminetetramethylenephosphate (EDTMP) in the treatment of patients with painful bone metastases
Eur J Cancer
(1997) - et al.
Use of bisphosphonates in cancer patients
Cancer Treat Rev
(1996) - et al.
Relationships between biochemical and symptomatic response in a double-blind trial of pamidronate for metastatic bone disease
Ann Oncol
(1997) - et al.
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma
Lancet
(1992) - et al.
Markers of bone resorption in patients treated with pamidronate
Eur J Cancer
(1998)
Double-blind, randomised, placebo-controlled study of oral ibandronate in patients with metastatic bone disease
Ann Oncol
(1999)
Reduced morbidity from skeletal metastases in breast cancer patients during long term bisphosphonate (APD) treatment
Lancet
(1987)
The role of the vertebral veins in the metastatic process
Ann Intern Med
(1942)
Generalised increase in bone resorption in carcinoma of the prostate
Br J Urol
(1985)
Biochemical markers of malignant bone disease
Rubens RD, Mundy GR eds Cancer and the Skeleton
(2000)
Tumour progression and angiogenesis in bone metastases from breast cancer: new approaches to an old problem
Cancer Treat Rev
(2000)
Prognostic factors in stage D2 prostate cancer: important implications for future trials: results of a Co-operative Intergroup Study (INT 0036)
Semin Oncol
(1994)
Multiple myeloma and related disorders
Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE eds, Clinical Oncology, 2nd edn
(2000)
Clinical course and prognostic factors following recurrence from breast cancer
Br J Cancer
(1998)
The clinical course of bone metastases from breast cancer
Br J Cancer
(1987)
Bisphosphonates in the treatment of multiple myeloma
Hypercalcaemia
Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathological fracture
Clin Orthop Rel Res
(1989)
Early detection of spinal epidural metastases: the role of myelography
Ann Neurol
(1986)
Spinal stabilisation
Rubens RD, Mundy GR eds, Cancer and the Skeleton
(2000)
Cited by (0)
Copyright © 2001 Harcourt Publishers Ltd. All rights reserved.